WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992000078) ANTIVIRAL AGENTS CONTAINING HETEROPOLYTUNGSTATE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/000078    International Application No.:    PCT/AU1991/000280
Publication Date: 09.01.1992 International Filing Date: 28.06.1991
Chapter 2 Demand Filed:    16.12.1991    
IPC:
A61K 31/66 (2006.01), A61K 33/42 (2006.01), C01B 25/45 (2006.01)
Applicants: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION [AU/AU]; Limestone Avenue, Campbell, ACT 2601 (AU) (For All Designated States Except US).
FAIRFIELD HOSPITAL BOARD [AU/AU]; Yarra Bend Road, Fairfield, VIC 3078 (AU) (For All Designated States Except US).
MACFARLANE BURNET CENTRE FOR MEDICAL RESEARCH LIMITED [AU/AU]; Yarra Bend Road, Fairfield, VIC 3078 (AU) (For All Designated States Except US).
WEIGOLD, Helmut [AU/AU]; (AU) (For US Only).
HOLAN, George [AU/AU]; (AU) (For US Only).
MARCUCCIO, Sebastian, Mario [AU/AU]; (AU) (For US Only).
BIRCH, Christopher, John [AU/AU]; (AU) (For US Only).
GUST, Ian, David [AU/AU]; (AU) (For US Only)
Inventors: WEIGOLD, Helmut; (AU).
HOLAN, George; (AU).
MARCUCCIO, Sebastian, Mario; (AU).
BIRCH, Christopher, John; (AU).
GUST, Ian, David; (AU)
Agent: CORBETT, Terence, Guy; Davies & Collison, 1 Little Collins Street, Melbourne, VIC 3000 (AU)
Priority Data:
PK 0917 29.06.1990 AU
Title (EN) ANTIVIRAL AGENTS CONTAINING HETEROPOLYTUNGSTATE
(FR) AGENTS ANTIVIRAUX CONTENANT DE L'HETEROPOLYTUNGSTATE
Abstract: front page image
(EN)Heteropolytungstate compounds of general formulae (I), wherein M is Co, Fe, Zn, FeOA, FeO¿1/2?; Cp represents an optionally substituted cyclopentadienyl residue; A is a monovalent or divalent cation or mixture of such cations; m is the number of cations necessary for electrical neutrality of the molecule; or pharmaceutically acceptable derivatives thereof. Pharmaceutical compositions or methods for the treatment or prophylaxis of retrovirus-associated infection which involve the use of such compounds.
(FR)Composés d'hétéropolytungstate des formules générales (I) où M représente Co, Fe, Zn, FeOA, FeO¿1/2?; Cp représente un résidu de cyclopentadiényle éventuellement substitué; A représente un cation univalent ou bivalent ou un mélange de tels cations; m représente le nombre de cations nécessaires à la neutralité électrique de la molécule; ou des dérivés pharmaceutiquement acceptables de ces éléments. Des compositions pharmaceutiques ou des méthodes destinées au traitement ou à la prophylaxie d'infections associées aux rétrovirus et préconisant l'utilisation de tels composés sont aussi décrites.
Designated States: AT, AU, BB, BG, BR, CA, CH, CS, DE, DK, ES, FI, GB, HU, JP, KP, KR, LK, LU, MC, MG, MW, NL, NO, PL, RO, SD, SE, SU, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)